Companies: 10,795·Total market cap: $144.5T
NDT Pharmaceuticals Inc.

NDT Pharmaceuticals Inc.

NDTPOTCHealthcare● Active
$0.50
+$0.20(+66.98%)
Market Cap$80150979
P/E Ratio—
52W High$2.1
52W Low$0.0466
SEC Filings

NDT Pharmaceuticals Inc. (NDTP) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001329944 · NDTP · OTC · as of Jun 9, 2026

Filing snapshot

25
Total Filings
10-Q
Latest Form
2019-10-30
Most Recent
2008
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001329944 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2008-04-08
Fiscal Year End
Apr 8, 2008
Accession No.
0001211524-08-000086
Primary Document
mistral10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001329944 · Accession 0001211524-08-000086

Latest Key Filings

10-QQuarterly Report
MISTRAL VENTURES,, INC. - FORM 10-Q (06/30/2008)
2019-10-30
View 10-Q on SEC
8-KCurrent Report
CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
2019-10-28Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
MISTRAL VENTURES,, INC. - FORM 10-Q (06/30/2008)
2019-10-30
View
8-KCurrent Report
CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
2019-10-28
View
15-12G15-12G
MISTRAL TERMINATION
2008-08-14
View
8-KCurrent Report
MISTRAL VENTURES
2008-07-25
View
10-QQuarterly Report
MISTRAL VENTURES MARCH 2008
2008-05-14
View
10-KAnnual Report
MISTRAL VENTURES
2008-04-08
View
NT 10-KNT 10-K
MISTRAL
2008-03-31
View
10QSB10QSB
MISTRAL SEPT 2007
2007-11-14
View
8-KCurrent Report
Current Report
2007-11-05
View
8-KCurrent Report
MISTRAL VENTURES FORWARD SPLIT
2007-09-11
View
10QSB10QSB
MISTRAL VENTURES JUNE 2007
2007-08-14
View
3/AInitial Statement of Beneficial Ownership (Amended)
PRIMARY DOCUMENT
2007-08-13
View
8-KCurrent Report
MISTRAL VENTURES
2007-06-08
View
10QSB10QSB
MISTRAL MAR 2007
2007-05-14
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2007-05-10
View
Showing 1–15 of 24 filingsForm 4 / 144 hidden· 25 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001329944  |  Exchange: OTC · Healthcare

NDT Pharmaceuticals Inc. (OTC: NDTP) has submitted 25 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2008. As a Healthcare sector company with CIK 0001329944, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is NDT Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent NDT Pharmaceuticals Inc. 10-K was filed on 2008-04-08 for fiscal year ending 2008. Historical NDTP 10-K annual reports are available from 2006 through 2008.

Investors researching NDT Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
SCNLF SEC Filings →NGENF SEC Filings →KNTPF SEC Filings →IPHYF SEC Filings →BRIBF SEC Filings →JWCTF SEC Filings →AAWH SEC Filings →MLLCF SEC Filings →
→ NDTP Financials→ NDTP Earnings→ NDTP Insider Trades

Frequently Asked Questions

NDTP SEC Filings · 8 questions

NDT Pharmaceuticals Inc. (NDTP) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 25 filings and access original documents at no cost. NDT Pharmaceuticals Inc.'s CIK is 0001329944.

NDTP SEC filingsNDT Pharmaceuticals Inc. SEC documentsfind NDTP 10-K